A More Pleasant Way
to Screen for Colon Cancer

Screening for Early Signs of Cancer

Our Shield™ blood test offers individuals a more pleasant and convenient screening option that helps overcome barriers associated with available methods, including colonoscopy and stool-based testing, which can be unpleasant, time-consuming and difficult to complete.

Learn More About Shield
Male doctor and female patient discuss.

Provider Resources

Explore resources designed to help healthcare providers understand the clinical evidence supporting Shield, our revolutionary blood-based screening test for colorectal cancer.

With a focus on safety and efficacy, these materials provide valuable insights into how Shield can help overcome screening challenges and help guide informed decision-making in your practice.

Access Resources

Closing the Gap

Cancer screening is a proven way to detect cancer early, when it’s most treatable. However, 1 in 3 eligible Americans do not complete colorectal cancer screening in part because they find the current options unpleasant or inconvenient.1

Blood-based screening tests like Shield that can be completed as part of a simple blood draw have the potential to improve screening adherence and identify more cancers early, when they are most treatable.

Our ECLIPSE study validates Shield as a high-sensitivity blood test for colorectal cancer screening.
Explore Our Cancer Screening Studies

Learn More About Shield

Interested in learning more about our Shield blood test for early cancer screening?

Visit ShieldCancerScreen.com

  1. Westesson O, Axelrod H, Dean J, He Y, Sample P, Zotenko E, et al. Abstract 2316: Integrated genomic and epigenomic cell-free DNA (cfDNA) analysis for the detection of early-stage colorectal cancer. Proceedings: AACR Annual Meeting 2020; Cancer Res 2020;80; 10.1158/1538-7445.AM2020-2316.<